Page of

Polymyalgia rheumatica 

Polymyalgia rheumatica
Polymyalgia rheumatica
Oxford Textbook of Rheumatology (4 ed.)

Bhaskar Dasgupta

and Charles Raine

Previous versions of this chapter are available. To view earlier versions of this chapter view the full site here.

This chapter reviews advances in pathogenesis; European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria with clinical, laboratory, and ultrasound criteria for classification as polymyalgia rheumatica (PMR); the heterogeneity and overlap between PMR, inflammatory arthritis, and large-vessel vasculitis as illustrated by representative cases; pathogenesis; recent guidelines on early and correct recognition, investigations, and management of PMR; the scope of disease-modifying agents; socio-economic impact, outcomes, and patient experience in PMR. It also discusses areas for future research including clinical trials with biological agents and newer steroid formulations, standardized outcome assessments, and the search for better biomarkers in PMR.

Sign In

Copyright © 2020. All rights reserved.